The structural stability of the HIV-1 protease

Journal of Molecular Biology

Volumn 283, Issue 2, 1998, Pages 475-488

  Todd, Matthew J ^a   Semo, Nora ^a   Freire, Ernesto ^a  

^a Dept Biol Biocalorimetry Ctr J ^*  (United States)

Author keywords

AIDS; HIV protease; HIV protease calorimetry; HIV protease dimerization; HIV protease stability

Indexed keywords

PROTEINASE; PROTEINASE INHIBITOR; VIRUS ENZYME;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DIMERIZATION; DISSOCIATION CONSTANT; ENERGY TRANSFER; ENTHALPY; ENTROPY; ENZYME CONFORMATION; ENZYME STABILITY; ENZYME STRUCTURE; ENZYME SUBUNIT; GENE MUTATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PH; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN FOLDING; PROTON TRANSPORT; THERMODYNAMICS; THERMOSTABILITY; ULTRAVIOLET SPECTROSCOPY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032561137     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1998.2090     Document Type: Article

References (42)

1. Abdel-Meguid S.S., Metcalf B.W., Carr T.J., Demarsh P., DesJarlais R.L., Fisher S., Green D.W., Ivanoff L., Lambert D.M., Murthy K.H.M., Petteway J.S.R., Pitts W.J., Tomaszek J.T.A., Winborne E., Baoguang Zhao B., Dreyer G.B., Meek T.D. An orally bioavailable HIV-1 protease inhibitor containing an imidazole-derived peptide bond replacement crystallographic and pharmacokinetic analysis. Biochemistry. 33:1994;11671-11677
2. Ala P.J., Huston E.E., Klabe R.M., McCabe D.D., Duke J.L., Rizzo C.J., Korant B.D., DeLoskey R.J., Lam P.Y.S., Hodge C.N., Chang C.W. Molecular basis of HIV-1 protease drug resistance structural analysis of mutant proteases complexed with cyclic urea inhibitors. Biochemistry. 36:1997;1573-1580
3. Babe L.M., Rose J., Craik C.S. Synthetic "interface" peptides after dimeric assembly of the HIV 1 and 2 proteases. Protein Sci. 1:1992;1244-1253
4. Baldwin E.T., Bhat T.N., Liu B., Pattabiraman N., Erickson J.W. Structural basis of drug resistance for the V82A mutant of HIV-1 protease backbone flexibility and substrate repacking. Nature Struct. Biol. 2:1995;244-249
5. Bardi J.S., Luque I., Freire E. Structure-based thermodynamic analysis of HIV-1 protease inhibitors. Biochemistry. 36:1997;6588-6596
6. Boudker O., Todd M.J., Freire E. The structural stability of the co-chaperonin GroES. J. Mol. Biol. 272:1997;770-779
7. Chen Z., Li Y., Chen E., Hall D.L., Darke P.L., Culberson C., Shafer J.A., Kuo L.C. Crystal structure at 1.9 angstroms resolution of human immunodeficiency virus (HIV) I protease complexed with an orally bioavailable inhibitor of the HIV proteases. J. Biol. Chem. 269:1994;26344
8. D'Aquino J.A., Gómez J., Hilser V.J., Lee K.H., Amzel L.M., Freire E. The magnitude of the backbone conformational entropy change in protein folding. Proteins: Struct. Funct. Genet. 25:1996;143-156
9. Erickson J.W., Neidhart D.J., Van Drie J., Kempf D.J., Wang X.C., Norbeck D.W., Plattner J.J., Rittenhouse J.W., Turon M., Wideburg N., Kohlbrenner W.E., Simmer R., Helfrich R., Paul D.A., Knigge M. Design, activity and 2.8 angstroms crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease. Science. 249:1990;527-529
10. Fitzgerald P.M.D., Mc Keever B.M., Van Middlesworth J.F., Springer J.P., Heimbach J.C., Leu C.-T., Herber W.K., Dixon R.A.F., Darke P.L. Crystallographic analysis of a complex between human immunodefficiency virus type I protease and acetyl pepstatin at 2 resolution. J. Biol. Chem. 265:1990;14209-14218
11. Gomez J., Freire E. Thermodynamic mapping of the inhibitor site of the aspartic protease endothiapepsin. J. Mol. Biol. 252:1995;337-350
12. Gomez J., Hilser J.V., Xie D., Freire E. The heat capacity of proteins. Proteins: Struct. Funct. Genet. 22:1995;404-412
13. Grant S.K., Deckman I.C., Culp J.S., Minnich M.D., Brooks I.S., Hensley P., Debouck C., Meek T.D. Use of protein unfolding studies to determine the conformational and dimeric stabilities of HIV-1 and SIV proteases. Biochemistry. 31:1992;9491-9501
14. Greene R.F., Pace C.N. Urea and guanidine hydrochloride denaturation of ribonuclease, lysozyme, α-chymotrypsin, and β-lactoglobulin. J. Biol. Chem. 249:1974;5388-5393
15. Hilser V.J., Freire E. Structure based calculation of the equilibrium folding pathway of proteins. Correlation with hydrogen exchange protection factors. J. Mol. Biol. 262:1996;756-772
16. Hilser V.J., Freire E. Predicting the equilibrium protein folding pathway structure-based analysis of Staphylococcal nuclease. Proteins: Struct. Funct. Genet. 27:1997;171-183
17. Hilser V.J., Gomez J., Freire E. The enthalpy change in protein folding and binding. refinement of parameters for structure based calculations. Proteins: Struct. Funct. Genet. 26:1996;123-133
18. Hilser V.J., Townsend B.D., Freire E. Structure-based statistical thermodynamic analysis of T4 lysozyme mutants structural mapping of cooperative interactions. Biophys. Chem. 64:1997;69-79
19. Hong L., Treharne A., Hartsuck J.A., Foundling S., Tang J. Crystal structures of complexes of a peptidic inhibitor with wild-type and two mutant HIV-1 proteases. Biochemistry. 35:1996;10627-10633
20. Johnson C.R., Freire E. Structural stability of oligomeric proteins. Techniques Protein Chem. VII:1996;459-467
21. Johnson C.R., Morin P.E., Arrowsmith C.H., Freire E. Thermodynamic analysis of the structural stability of the tetrameric oligomerization domain of p53 tumor suppresor. Biochemistry. 34:1995;5309-5316
22. Kenar K.T. Thermodynamic characterization of the structural stability of the GCN4 leucine zipper dimer. 1994;The Johns Hopkins University. Ph. D. Dissertation
23. Kim E.E., Baker C.T., Dwyer M.D., Murcko M.A., Rao B.G., Tung R.D., Navia M.A. Crystal structure of HIV-1 protease in complex with VX_478, a potent and orally bioavailable inhibitor of the enzyme. J. Am. Chem. Soc. 117:1995;1181-1182
24. Luque I., Mayorga O., Freire E. Structure based thermodynamic scale of -helix propensities in amino acids. Biochemistry. 35:1996;13681-13688
25. Luque I., Todd M.J., Gomez J., Semo N., Freire E. The molecular basis of resistance to HIV-1 protease inhibition a plausible hypothesis. Biochemistry. 37:1998;5791-5797
26. Madhusoodan V.H., Bhat T.N., Kempf D.J., Baldwin E.T., Liu B., Gulnik S., Wideburg N.E., Norbeck D.W., Appelt K., Erickson J.W. Influence of stereochemistry on activity and binding modes for C2 symmetry-based diol inhibitors of HIV-1 protease. J. Am. Chem. Soc. 116:1994;847-855
27. Mildner A.M., Rothrock D.J., Leone J.W., Bannow C.A., Lull J.M., Reardon I.M., Sarcich J.L., Howe W.J., Tomich C.C., Smith C.W., Heinrickson R.L., Tomasselli A.G. The HIV-1 protease as enzyme and substrate mutagenesis of autolysis sites and generation of a stable mutant with retained kinetic properties. Biochemistry. 33:1994;9405-9413
28. Miller M., Schneider J., Sathyanarayana B.K., Toth M.V., Marshall G.R., Clawson L., Selk L., Kent S.B.H., Wlodawer A. Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 resolution. Science. 246:1989;1149-1153
29. Murphy K.P., Freire E. Thermodynamics of structural stability and cooperative folding behavior in proteins. Advan. Protein Chem. 43:1992;313-361
30. Myers J.K., Pace C.N., Scholtz J.M. Denaturant m values and heat capacity changes relation to changes in accessible surface areas of protein unfolding. Protein Sci. 4:1995;2138-2148
31. Nicholls A., Bharadwaj R., Honig B. GRASP graphical representation and analysis of surface properties. Biophys. J. 64:1993;166-170
32. Privalov G., Kavina V., Freire E., Privalov P.L. Precise scanning calorimeter for studying thermal properties of biological macromolecules in dilute solution. Anal. Biochem. 232:1995;79-85
33. Privalov P.L. Stability of proteins small globular proteins. Advan. Protein Chem. 33:1979;167-239
34. Robertson A.D., Murphy K.P. Protein structure and the energetics of protein stability. Chem. Rev. 97:1997;1251-1267
35. Spinelli S., Liu Q.Z., Alzari P.M., Hirel P.H., Poljak R.J. The three-dimensional structure of the aspartyl protease from the HIV-1 isolate BRU. Biochimie. 73:1991;1391-1396
36. Stark G.R. Reactions of cyanate with functional groups of proteins. III. Reactions with amino and carboxyl group. Biochemistry. 4:1965;1030-1036
37. Szeltner Z., Polgar L. Conformational stability and catalytic activity of HIV-1 protease are both enhanced at high salt concentration. J. Biol. Chem. 271:1996;5458-5463
38. Thompson K., Vinson C., Freire E. Thermodynamic characterization of the structural stability of the coiled-coil region of the bZIP transcription factor GCN4. Biochemistry. 32:1993;5491-5496
39. Warner R.C. The kinetics of the hydrolysis of urea and of arginine. J. Biol. Chem. 142:1941;705-723
40. Wlodawer A., Erickson J.W. Structure-based inhibitors of HIV-1 protease. Annu. Rev. Biochem. 62:1993;543-585
41. Zhang Z.-Y., Poorman R.A., Maggiora L.L., Heinrickson R.L., Kezdy F.J. Dissociative inhibition of dimeric enzymes. Kinetic characterization of the inhibition of HIV-1 protease by its COOH terminal tetrapeptide. J. Biol. Chem. 266:1991;15591-15594
42. Zutshi R., Franciskovich J., Shultz M., Schweitzer B., Bishop P., Wilson M., Chmielewski J. Targeting the dimerization interface of HIV-1 protease inhibition with cross-linked interfacial peptides. J. Am. Chem. Soc. 119:1997;4841-4845